JP5453609B2 - 可鍛性タンパク質マトリクス及びその使用 - Google Patents

可鍛性タンパク質マトリクス及びその使用 Download PDF

Info

Publication number
JP5453609B2
JP5453609B2 JP2003553926A JP2003553926A JP5453609B2 JP 5453609 B2 JP5453609 B2 JP 5453609B2 JP 2003553926 A JP2003553926 A JP 2003553926A JP 2003553926 A JP2003553926 A JP 2003553926A JP 5453609 B2 JP5453609 B2 JP 5453609B2
Authority
JP
Japan
Prior art keywords
lactobacillus
mpm
protein
whey
bifidobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003553926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513076A5 (enExample
JP2005513076A (ja
Inventor
シマール，エリック
ピロート，ドミニク
デュポン，クロードゥ
ラジョワ，ナタリー
パケ，マルセル
ルミュー，ピエール
ゴイエット，フィリップ
Original Assignee
バイオラクティス インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオラクティス インコーポレイティド filed Critical バイオラクティス インコーポレイティド
Publication of JP2005513076A publication Critical patent/JP2005513076A/ja
Publication of JP2005513076A5 publication Critical patent/JP2005513076A5/ja
Application granted granted Critical
Publication of JP5453609B2 publication Critical patent/JP5453609B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C13/00—Cream; Cream preparations; Making thereof
    • A23C13/12—Cream preparations
    • A23C13/14—Cream preparations containing milk products or non-fat milk components
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/16—Butter having reduced fat content
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/22—Working-up of proteins for foodstuffs by texturising
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60—Salad dressings; Mayonnaise; Ketchup
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/155—Kefiri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Developmental Biology & Embryology (AREA)
JP2003553926A 2001-12-20 2002-12-20 可鍛性タンパク質マトリクス及びその使用 Expired - Fee Related JP5453609B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34123201P 2001-12-20 2001-12-20
US60/341,232 2001-12-20
PCT/CA2002/001988 WO2003053158A2 (en) 2001-12-20 2002-12-20 Malleable protein matrix and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011123850A Division JP5249386B2 (ja) 2001-12-20 2011-06-01 可鍛性タンパク質マトリクス及びその使用

Publications (3)

Publication Number Publication Date
JP2005513076A JP2005513076A (ja) 2005-05-12
JP2005513076A5 JP2005513076A5 (enExample) 2006-02-16
JP5453609B2 true JP5453609B2 (ja) 2014-03-26

Family

ID=23336741

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003553926A Expired - Fee Related JP5453609B2 (ja) 2001-12-20 2002-12-20 可鍛性タンパク質マトリクス及びその使用
JP2011123850A Expired - Fee Related JP5249386B2 (ja) 2001-12-20 2011-06-01 可鍛性タンパク質マトリクス及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011123850A Expired - Fee Related JP5249386B2 (ja) 2001-12-20 2011-06-01 可鍛性タンパク質マトリクス及びその使用

Country Status (8)

Country Link
US (2) US20060057131A1 (enExample)
EP (1) EP1458247B1 (enExample)
JP (2) JP5453609B2 (enExample)
AU (1) AU2002351606A1 (enExample)
CA (1) CA2470776A1 (enExample)
ES (1) ES2451618T3 (enExample)
MX (1) MXPA04006082A (enExample)
WO (1) WO2003053158A2 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1569616A2 (en) * 2002-12-04 2005-09-07 Technologies Biolactis Inc. An exopolysaccharides delivery system for active molecules
NZ526804A (en) * 2003-07-02 2006-03-31 Fonterra Co Operative Group Process for producing a modified dairy product
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
BR0304083A (pt) * 2003-10-31 2005-06-28 Maria De Lourdes M Velly Processo de obtenção e beneficiamento do gel, da lâmina, do pó e das soluções produzidas do material protéico da rã, queratina em filme ou não e colágenos do tipo 2,4 e 6; processo de transformação deste material protéicos em gel, em lâmina, em pó, em soluções; uso do gel, uso do pó, uso da lâmina, uso das soluções, uso das aplicações destes produtos e destes materiais em formulações, uso das transformações destes produtos e destes materiais protéicos da rã
US7323204B2 (en) 2004-06-25 2008-01-29 Kraft Foods Holdings, Inc. Stabilization of fresh mozzarella cheese using fermented whey
US20090130072A1 (en) * 2005-02-11 2009-05-21 Pierre Lemieux Use of Lactobacillus Kefiranofaciens as a Probiotic and a Synbiotic
US20060182705A1 (en) * 2005-02-11 2006-08-17 Cruse Maria K Composition for reduction and prevention of wrinkles on the skin
CN100450375C (zh) * 2006-06-09 2009-01-14 大连轻工业学院 一种复合微生态饲料添加剂及其生产方法
FR2906442B1 (fr) * 2006-10-02 2010-12-17 Gervais Danone Sa Utilisation de la gomme arabique pour ameliorer la croissance et la survie des bifidobacteries.
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
TW200904340A (en) * 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
EP2205259B1 (en) * 2007-10-02 2014-12-10 Institut National de la Recherche Scientifique Mpm (malleable protein matrix) for use in the treatment of arthritis, obesity, insulin resistance, type 2 diabetes, autoimmune disease, hypertension, and hyperlipidemia
WO2009127057A1 (en) * 2008-04-15 2009-10-22 Innovactiv Inc. Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof
US8241690B2 (en) 2008-11-14 2012-08-14 Kraft Foods Global Brands Llc Method of making fresh cheese with enhanced microbiological safety
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20130029906A1 (en) * 2009-12-04 2013-01-31 Eric Simard Method of regulating ppar, obesity related pathways and their associated metabolic impact
CA2799452A1 (en) * 2010-05-14 2011-11-17 Lactoscience Inc. Fermentation process of a substrate using a mixed culture for the production of an edible biomass for animal and/or human consumption
WO2012057636A1 (en) * 2010-10-27 2012-05-03 Fonterra Corporate Research And Development Limited Modulation of th1 and th2 immune response by lactic acid whey
US20120258230A1 (en) * 2011-04-08 2012-10-11 Tic Gums, Inc. Thickening and emulsifying guar gum and guar blends conjugated with endogenous and exogenous proteins
CN102396688B (zh) * 2011-11-02 2013-05-08 华南理工大学 呈味活性肽及其制备方法与应用
BR112015003239B1 (pt) 2012-08-22 2020-10-27 Kraft Foods Group Brands Llc queijo processado incluindo antimicrobianos naturais e método para produção de um queijo processado tendo antimicrobianos naturais
US9808493B2 (en) 2012-08-31 2017-11-07 University College Cork—National University of Ireland, Cork Exopolysaccharide-producing bacteria, and uses thereof for protecting heart health
WO2014149468A1 (en) * 2013-03-15 2014-09-25 Halliburton Energy Services, Inc. Methods of biosynthesizing bacterial extracellular galactomannan polysaccharides and subunits thereof for use in subterranean formation operations
AU2014364034B2 (en) * 2013-12-10 2018-09-13 Kraft Foods Group Brands Llc Processed cheese with natural antibacterial and antimycotic components and method of manufacturing
CN107629119B (zh) * 2016-07-18 2021-05-14 河南工业大学 一种麦胚抗肿瘤活性蛋白的修饰方法
CA3036967A1 (en) * 2016-09-14 2018-03-22 Glanbia Nutritionals (Ireland) Ltd. Agglomerated protein products and method for making
FR3065623B1 (fr) 2017-04-28 2021-07-09 Roquette Freres Albumines de pois ameliorees, procede d'obtention et leurs applications
CN108617770A (zh) * 2018-05-14 2018-10-09 戴来花 低乳糖杀菌羊奶及其制作方法
CN108740012A (zh) * 2018-06-04 2018-11-06 安徽安亳食品有限公司 一种黄秋葵酸奶及其制备方法
CN109497558A (zh) * 2018-11-13 2019-03-22 南京中医药大学 苦参药渣多糖合生元及其制备方法与应用
KR102112949B1 (ko) * 2019-02-12 2020-05-19 남현규 복합 효모 발효로 불용 단백질을 가용화하여 화장품원료를 추출하는 화장품원료 제조방법
MX2019002435A (es) * 2019-02-28 2020-09-01 Bioactivos Y Nutraceuticos De Mexico S A De C V Formulaciones proteicas conjugadas con efecto nutracéutico y su método de preparación.
KR102283326B1 (ko) * 2019-05-27 2021-07-29 주식회사 단정바이오 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물
CN111793584B (zh) * 2020-08-05 2021-11-02 四川省农业科学院农产品加工研究所 鼠李糖乳杆菌菌株d2及其制备方法和用途
CN114886087A (zh) * 2021-01-26 2022-08-12 苏州乐卡食品有限公司 一种益生菌发酵豆乳及制备方法
CN113088479B (zh) * 2021-05-08 2022-08-26 河北农业大学 一种促进雪莲菌增殖的复合添加剂
CN113403228A (zh) * 2021-06-09 2021-09-17 南昌大学 一株产热稳定和pH稳定细菌素的乳酸乳球菌及其筛选方法和应用
CN113388511A (zh) * 2021-07-02 2021-09-14 泉州市嗣家名茶发展有限公司 一种束萃法提取秋葵果实中植物蛋白质的装置及方法
CN114796001B (zh) * 2022-04-17 2023-11-14 上海佰莱美生物科技有限公司 抗氧化组合物及其制备和在食品/化妆品中的应用
CN117683117B (zh) * 2023-12-11 2025-10-28 厦门元之道生物科技有限公司 一种具有减肥、抗糖化及抗炎活性的弹性蛋白肽及其制备方法、功能产品
CN118743634A (zh) * 2024-07-22 2024-10-08 广州迷紫化妆品有限公司 一种美白洁面组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209389A (en) * 1974-07-29 1980-06-24 Hartkorn Karl Heinz Microbiological method for removing pathogenic microbes and dissolved organic materials from liquids
US4073688A (en) * 1975-12-29 1978-02-14 Vysoka Skola Chemicko-Technologicka Process for the preparation of a proteinaceous concentrate
GB1549573A (en) * 1977-02-25 1979-08-08 British Petroleum Co Fermentation process for the production of a protein rich animal feedstuff from liquid dairy by-products
US4183966A (en) * 1978-04-14 1980-01-15 The Board of Regents of the Oklahoma Agricultural & Mechanical Colleges acting for and on behalf of Oklahoma State University of Agriculture and Applied Science Method of manufacturing a high protein snack food
US4444793A (en) * 1981-08-07 1984-04-24 Stauffer Chemical Company Fermentation of whey to produce a thickening agent
US4741337A (en) * 1985-07-17 1988-05-03 Ethicon, Inc. Surgical fastener made from glycolide-rich polymer blends
JPS62151155A (ja) * 1985-09-17 1987-07-06 Ajinomoto Co Inc チ−ズホエ−を原料とする調味料の製造方法
JP2506349B2 (ja) * 1986-10-28 1996-06-12 協同乳業株式会社 スプレツド状食品
JP2514387B2 (ja) * 1987-12-03 1996-07-10 雪印乳業株式会社 ホエ―蛋白質を原料とするナチュラルチ―ズ様食品の製造方法
US5456924A (en) 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
US5888552A (en) * 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
US5230902A (en) * 1988-04-29 1993-07-27 Immunotec Research Corporation Undenatured whey protein concentrate to improve active systemic humoral immune response
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
JP2811316B2 (ja) * 1989-02-20 1998-10-15 協同乳業株式会社 乳酸菌飲料とその製造方法
WO1992006598A1 (en) * 1990-10-23 1992-04-30 Kraft General Foods, Inc. Non-fat natural cheese
JPH0771448B2 (ja) * 1990-11-22 1995-08-02 雪印乳業株式会社 ノンファットアイスクリーム及びその製造法
FR2672613B1 (fr) * 1991-02-08 1994-05-27 Rochade Soc Civ Procede de fabrication d'un nouveau levain lactique, nouveau levain obtenu, fabrication d'additif alimentaire notamment probiotique a partir de ce levain et produit obtenu.
JPH07104A (ja) * 1993-06-14 1995-01-06 Morinaga Milk Ind Co Ltd 発酵乳及びその製造方法
JP2683491B2 (ja) * 1993-09-30 1997-11-26 雪印乳業株式会社 ホエー蛋白質発酵乳およびその製造方法
JP2607344B2 (ja) * 1993-09-30 1997-05-07 雪印乳業株式会社 ホエー蛋白質ゲル化物の製造方法およびホエー蛋白質を利用した加工食品の製造方法
JP3253797B2 (ja) * 1994-03-30 2002-02-04 雪印乳業株式会社 ホエータンパク質チーズ及びその製造方法
JPH08238078A (ja) * 1995-03-03 1996-09-17 Snow Brand Milk Prod Co Ltd ソース類の製造方法
US5756136A (en) * 1995-06-02 1998-05-26 Mccormick & Company, Inc. Controlled release encapsulation compositions
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative

Also Published As

Publication number Publication date
EP1458247A2 (en) 2004-09-22
MXPA04006082A (es) 2005-11-17
JP2005513076A (ja) 2005-05-12
JP5249386B2 (ja) 2013-07-31
AU2002351606A1 (en) 2003-07-09
JP2011224011A (ja) 2011-11-10
US20140328878A1 (en) 2014-11-06
EP1458247B1 (en) 2014-01-22
WO2003053158A2 (en) 2003-07-03
WO2003053158A9 (en) 2004-04-08
ES2451618T3 (es) 2014-03-28
WO2003053158A3 (en) 2003-08-28
US20060057131A1 (en) 2006-03-16
CA2470776A1 (en) 2003-07-03
AU2002351606A8 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
JP5249386B2 (ja) 可鍛性タンパク質マトリクス及びその使用
Marshall Starter cultures for milk fermentation and their characteristics
CN1197956C (zh) 产生抗高血压二和三肽的瑞士乳杆菌
JP2009524640A (ja) 肥満及びそれに関連する疾患の治療及び予防のためのプロバイオティック微生物の使用
AU2010295508A1 (en) Probiotic stabilization
JP2009542204A (ja) ダイエット効果に優れた機能性乳酸菌発酵組成物
JP3400282B2 (ja) 脂質代謝改善剤およびそれを含有する食品
CZ20014219A3 (cs) Dietetický, nutriční nebo farmaceutický přípravek obsahující alkalickou sfingomyelinázu
JP7263678B2 (ja) 凝集又は沈殿が抑制された乳酸菌含有飲料の製造方法
JP5254682B2 (ja) 経口摂取用皮膚性状改善剤
JPH05252900A (ja) 免疫賦活組成物
JP6531893B2 (ja) 濾胞性ヘルパーｔ細胞増加剤
EP1541672A1 (en) Composition for promoting the proliferation of lactobacillus casei subsp. casei
Drouault et al. Effets des bactéries lactiques ingérées avec des laits fermentés sur la santé
JP3684205B2 (ja) ラクトコッカス・ラクチスｃｂｔ−１９及びこれを利用した抗菌培養液の分離濃縮物の製造方法並びにこれを包含する化粧料組成物
RU2605626C2 (ru) Способ получения бактериального препарата с пробиотической активностью
JP4473570B2 (ja) 生体内での微生物の生残性を向上させる方法及び生残性が向上した微生物
KR20230138497A (ko) 관절 기능 개선용 조성물
JP2006014654A (ja) 抗体含有食品
JP4689060B2 (ja) 免疫賦活組成物
JP2003081855A (ja) 脂質代謝改善剤およびそれを含有する食品
JP7586361B2 (ja) 破骨前駆細胞の破骨細胞への分化抑制用組成物及び骨代謝改善用組成物
Ramchandran Physico-chemical and therapeutic properties of low-fat yogurt as influenced by fat replacers, exopolysaccharides and probiotics
JP7539230B2 (ja) 免疫バランスの調節のための組成物
JP2024046233A (ja) 腸管バリアの改善のための組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080715

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081014

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091130

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100301

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130919

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131113

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131125

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20131210

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20131210

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees